Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Shanghai YingLi Pharmaceutical Co. Ltd.)"
Count: 17
Selected: 0
| NCT ID | Title |
|---|
| NCT06026501 | A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor | ||
| NCT05228600 | YL-13027 in Patients With Advanced Solid Tumors | ||
| NCT05119933 | A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation | ||
| NCT05457517 | A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors | ||
| NCT05429398 | A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor | ||
| NCT05274997 | A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma | ||
| NCT05173805 | Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation | ||
| NCT04975061 | A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Thymic Cancer | ||
| NCT04705090 | A Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma | ||
| NCT04500561 | YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial | ||
| NCT04379167 | A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma | ||
| NCT04370405 | A Study of YY-20394 in Participants With Relapsed/Refractory Follicular Non-Hodgkin's Lymphoma | ||
| NCT04279405 | A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies | ||
| NCT04108325 | A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma | ||
| NCT04049929 | A Phase I Study of YY-20394 in Patients With Advanced Solid Tumors | ||
| NCT03869632 | First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors | ||
| NCT03757000 | A Phase I Study of YY-20394 in Patients With B Cell Hematologic Malignancies |
